EE517 Cost-Effectiveness Analysis of Tafasitamab in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Greece

Autor: Karaiskou, M., Avgitidou, A., Vostitsanou, Z., Batsi, M., Bungey, G., Prawitz, T., Peter, B., Stafylas, P.
Zdroj: In Value in Health December 2023 26(12) Supplement:S151-S151
Databáze: ScienceDirect
Externí odkaz: